Loading clinical trials...
Loading clinical trials...
Observational Study for Patients With Newly Diagnosed Mantle Cell Lymphoma (MCL) Not Eligible for High-dose Therapy According to the Protocol Alternating R-CHOP and R-cytarabine Chemotherapy Regimen (3+3 Cycles)
Conditions
Start Date
April 1, 2012
Primary Completion Date
December 31, 2015
Completion Date
December 31, 2016
Last Updated
February 16, 2017
NCT05529069
NCT06263491
NCT05006716
NCT06026319
NCT03523975
NCT01804686
Lead Sponsor
Czech Lymphoma Study Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions